180 related articles for article (PubMed ID: 33467548)
21. Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.
Lehman SM; Donlan RM
Antimicrob Agents Chemother; 2015 Feb; 59(2):1127-37. PubMed ID: 25487795
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect and anti-biofilm ability assessment of a novel phage, phiPA1-3, against carbapenem-resistant Pseudomonas aeruginosa.
Tsai YC; Lee YP; Lin NT; Yang HH; Teh SH; Lin LC
Virus Res; 2023 Oct; 335():199178. PubMed ID: 37490958
[TBL] [Abstract][Full Text] [Related]
23. Bacteriophage Treatment before Chemical Disinfection Can Enhance Removal of Plastic-Surface-Associated Pseudomonas aeruginosa.
Stachler E; Kull A; Julian TR
Appl Environ Microbiol; 2021 Sep; 87(20):e0098021. PubMed ID: 34347517
[TBL] [Abstract][Full Text] [Related]
24. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
Maszewska A; Zygmunt M; Grzejdziak I; Różalski A
J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909
[TBL] [Abstract][Full Text] [Related]
25. Antibiofilm Efficacy of the Pseudomonas aeruginosa Pbunavirus vB_PaeM-SMS29 Loaded onto Dissolving Polyvinyl Alcohol Microneedles.
Sillankorva S; Pires L; Pastrana LM; Bañobre-López M
Viruses; 2022 May; 14(5):. PubMed ID: 35632706
[TBL] [Abstract][Full Text] [Related]
26. P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination.
Henriksen K; Rørbo N; Rybtke ML; Martinet MG; Tolker-Nielsen T; Høiby N; Middelboe M; Ciofu O
Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30821815
[TBL] [Abstract][Full Text] [Related]
27. Hyperthermia Prevents
Palau M; Muñoz E; Larrosa N; Gomis X; Márquez E; Len O; Almirante B; Gavaldà J
Microbiol Spectr; 2023 Feb; 11(1):e0280722. PubMed ID: 36472442
[TBL] [Abstract][Full Text] [Related]
28. Expression of virulence factors by Pseudomonas aeruginosa biofilm after bacteriophage infection.
Oliveira VC; Steixner S; Nascimento CD; Pagnano VO; Silva-Lovato CH; Paranhos HFO; Wilflingseder D; Coraça-Huber D; Watanabe E
Microb Pathog; 2021 May; 154():104834. PubMed ID: 33691179
[TBL] [Abstract][Full Text] [Related]
29. Development of expanded host range phage active on biofilms of multi-drug resistant
Mapes AC; Trautner BW; Liao KS; Ramig RF
Bacteriophage; 2016; 6(1):e1096995. PubMed ID: 27144083
[TBL] [Abstract][Full Text] [Related]
30. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
[TBL] [Abstract][Full Text] [Related]
31. Bacteriophage treatment of carbapenemase-producing
Santiago AJ; Burgos-Garay ML; Kartforosh L; Mazher M; Donlan RM
AIMS Microbiol; 2020; 6(1):43-63. PubMed ID: 32226914
[TBL] [Abstract][Full Text] [Related]
32. Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant
Kunz Coyne AJ; Stamper K; Kebriaei R; Holger DJ; El Ghali A; Morrisette T; Biswas B; Wilson M; Deschenes MV; Canfield GS; Duerkop BA; Arias CA; Rybak MJ
Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139953
[TBL] [Abstract][Full Text] [Related]
33. Characterization of two bacteriophages specific to Acinetobacter baumannii and their effects on catheters biofilm.
Erol HB; Kaskatepe B; Yildiz S; Altanlar N; Bayrakdar F
Cell Biochem Funct; 2024 Mar; 42(2):e3966. PubMed ID: 38444208
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Lytic Phage Cocktails on
Kifelew LG; Warner MS; Morales S; Thomas N; Gordon DL; Mitchell JG; Speck PG
Viruses; 2020 May; 12(5):. PubMed ID: 32443619
[TBL] [Abstract][Full Text] [Related]
35. The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study.
Jang CH; Park H; Cho YB; Choi CH; Park IY
Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):295-9. PubMed ID: 19095310
[TBL] [Abstract][Full Text] [Related]
36. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
Rossitto M; Fiscarelli EV; Rosati P
Front Microbiol; 2018; 9():775. PubMed ID: 29780361
[TBL] [Abstract][Full Text] [Related]
37. Biofilm eradication ability of phage cocktail against Listeria monocytogenes biofilms formed on food contact materials and effect on virulence-related genes and biofilm structure.
Byun KH; Han SH; Choi MW; Kim BH; Park SH; Ha SD
Food Res Int; 2022 Jul; 157():111367. PubMed ID: 35761627
[TBL] [Abstract][Full Text] [Related]
38. Characterization of newly isolated bacteriophage to control multi-drug resistant Pseudomonas aeruginosa colonizing incision wounds in a rat model: in vitro and in vivo approach.
Abo Kamer AM; Abdelaziz AA; Nosair AM; Al-Madboly LA
Life Sci; 2022 Dec; 310():121085. PubMed ID: 36265569
[TBL] [Abstract][Full Text] [Related]
39. Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections.
Chen B; Benavente LP; Chittò M; Wychowaniec JK; Post V; D'Este M; Constant C; Zeiter S; Feng W; Moreno MG; Trampuz A; Wagemans J; Onsea J; Richards RG; Lavigne R; Moriarty TF; Metsemakers WJ
J Control Release; 2023 Dec; 364():159-173. PubMed ID: 37866403
[TBL] [Abstract][Full Text] [Related]
40. Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant
Racenis K; Lacis J; Rezevska D; Mukane L; Vilde A; Putnins I; Djebara S; Merabishvili M; Pirnay JP; Kalnina M; Petersons A; Stradins P; Maurins S; Kroica J
Viruses; 2023 May; 15(5):. PubMed ID: 37243293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
